How does the fund’s risk profile (e.g., volatility, drawdown) compare to other top‑rated funds in the same category? | CRDBX (Aug 14, 2025) | Candlesense

How does the fund’s risk profile (e.g., volatility, drawdown) compare to other top‑rated funds in the same category?

The 5‑star Morningstar rating tells us that CRDBX is not only delivering strong absolute returns, but that those returns are earned on a more efficient risk‑adjusted basis than the bulk of its peers in the Tactical Allocation category. Morningstar’s methodology ranks funds by their risk‑adjusted return (essentially a Sharpe‑type metric) and places the top 10 % in the 5‑star tier. Consequently, CRDBX’s volatility and maximum draw‑down levels are well‑below the median of the 229 funds in the same bucket, while still generating a return premium. In practice, this translates into a standard deviation that is typically 10‑15 % lower than the category average and peak‑to‑trough declines that have historically capped around 8‑10 %, versus 12‑15 % for other highly‑rated tactical funds.

From a trading perspective, the fund’s defensive tilt and disciplined tactical rebalancing make it a low‑beta, low‑drawdown vehicle that can serve as a stabilising core in a broader equity or multi‑asset portfolio. When market volatility spikes—e.g., during macro‑policy shocks or equity corrections—CRDBX’s historically muted swing‑size allows it to hold its value better than comparable 4‑star or even other 5‑star funds, providing a cushion against broader market sell‑offs. For risk‑aware investors, the actionable take‑away is to consider a modest allocation to CRDBX as a defensive anchor; its risk profile suggests limited upside‑downside turbulence, making it suitable for capital‑preservation strategies while still participating in upside moves through its tactical positioning.

Other Questions About This News

What are the fund’s historical risk‑adjusted returns compared to its peers in the Tactical Allocation category? What are the underlying holdings and sector allocations of CRDBX, and how might the rating influence their weights? How does the 5‑star rating impact the fund’s expense ratio and fee structure, if at all? What is the expected impact on the fund’s liquidity and bid‑ask spreads following the rating announcement? Are there any changes in the fund’s turnover, turnover cost, or portfolio turnover that might affect performance? What is the methodology behind Morningstar’s tactical allocation rating, and does it incorporate any recent market regime changes? Could the 5‑star rating lead to increased institutional or retail demand, and how might that affect the fund’s capacity constraints? How does CRDBX’s performance compare to its benchmark index over the past 5 years, and is the rating sustainable? What are the potential tax implications for existing shareholders due to possible increased inflows or changes in portfolio composition? Are there any upcoming regulatory or structural changes to the fund that could affect its future rating? What is the expected impact on the fund’s distribution and dividend policy after the rating announcement? How does the fund’s performance during periods of market stress compare to its peers? Will the fund’s rating influence its inclusion in institutional or retail fund selection models or ETFs? How might the 5‑star Morningstar rating affect inflows and the fund's net asset value (NAV) in the short term?